Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2015, Article ID 817578, 4 pages
http://dx.doi.org/10.1155/2015/817578
Case Report

Is It Safe to Restart Antivascular Endothelial Growth Factor Therapy in Patients with Renal Cell Carcinoma after Cardiac Ischemia?

1Department of Hematology and Oncology, Cleveland Clinic, 9500 Euclid Avenue R35, Cleveland, OH 44195, USA
2Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue J3-4, Cleveland, OH 44195, USA

Received 16 July 2015; Accepted 30 September 2015

Academic Editor: Raffaele Palmirotta

Copyright © 2015 Bo Zhao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Bo Zhao, Laura S. Wood, Karen James, and Brian I. Rini, “Is It Safe to Restart Antivascular Endothelial Growth Factor Therapy in Patients with Renal Cell Carcinoma after Cardiac Ischemia?,” Case Reports in Oncological Medicine, vol. 2015, Article ID 817578, 4 pages, 2015. https://doi.org/10.1155/2015/817578.